Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan N Barker

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasisJohn Bowes, James Ashcroft, Nick Dand, et al.
American Journal of Human Genetics|April 2, 2021
Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin diseaseMarta Vergnano, Maja Mockenhaupt, Natashia Benzian-Olsson, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
American Journal of Human Genetics|May 6, 2014
AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 traffickingNiovi Setta-Kaffetzi, Michael A Simpson, Alexander A Navarini, et al.
American Journal of Human Genetics|August 8, 2020
Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin DiseaseMarta Vergnano, Maja Mockenhaupt, Natashia Benzian-Olsson, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flaresJames G Krueger, Mrinal K Sarkar, Mark G Lebwohl, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytesHaihan Zhang, Matthew T Patrick, Mrinal K Sarkar, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
The Journal of Investigative Dermatology|November 12, 2021
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with PsoriasisKonstantinos Douroudis, Ravi Ramessur, Ines A Barbosa, et al.
The Journal of Investigative Dermatology|January 9, 2016
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with PsoriasisAdrià Aterido, Antonio Julià, Carlos Ferrándiz, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasisJohn Bowes, James Ashcroft, Nick Dand, et al.
American Journal of Human Genetics|April 2, 2021
Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin diseaseMarta Vergnano, Maja Mockenhaupt, Natashia Benzian-Olsson, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
American Journal of Human Genetics|May 6, 2014
AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 traffickingNiovi Setta-Kaffetzi, Michael A Simpson, Alexander A Navarini, et al.
American Journal of Human Genetics|August 8, 2020
Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin DiseaseMarta Vergnano, Maja Mockenhaupt, Natashia Benzian-Olsson, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flaresJames G Krueger, Mrinal K Sarkar, Mark G Lebwohl, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytesHaihan Zhang, Matthew T Patrick, Mrinal K Sarkar, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasisNick Dand, Michael Duckworth, David Baudry, et al.
The Journal of Investigative Dermatology|November 12, 2021
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with PsoriasisKonstantinos Douroudis, Ravi Ramessur, Ines A Barbosa, et al.
The Journal of Investigative Dermatology|January 9, 2016
Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with PsoriasisAdrià Aterido, Antonio Julià, Carlos Ferrándiz, et al.
Pageof 11